Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00209339 · ClinicalTrials.gov registry record · Phase 1
Feasibility Study of a Percutaneous Mitral Valve Repair System.
A Phase 1 study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- Phase 1
- Development phase
- 55
- Enrollment target
NCT00209339 is a Phase 1 study that has completed, run by Abbott Medical Devices. The registered enrollment target is 55 participants.
The verdict
NCT00209339, a Phase 1 study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 55 participants
- Enrollment target
Study Summary
Prospective, multi-center, Phase I study of the Evalve Cardiovascular Valve Repair System (CVRS) in the treatment of mitral valve regurgitation. Patients will undergo 30-day, 6 month, 12 month, and 5 year clinical follow-up.
Interventions
- DEVICE Percutaneous mitral valve repair (MitraClip Implant)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2003-07 |
| Est. Completion | 2011-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00209339
The ClinicalTrials.gov registry entry for NCT00209339 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous mitral valve repair (MitraClip Implant) is the first listed.
NCT00209339 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00209339 about?
NCT00209339 is a clinical study titled "Feasibility Study of a Percutaneous Mitral Valve Repair System.". Prospective, multi-center, Phase I study of the Evalve Cardiovascular Valve Repair System (CVRS) in the treatment of mitral valve regurgitation. Patients will undergo 30-day, 6 month, 12 month, and 5 year clinical follow-up.
What is the current status of trial NCT00209339?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 55 participants. The study started on 2003-07. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00209339?
The interventions under investigation include: Percutaneous mitral valve repair (MitraClip Implant) (DEVICE).
Who is sponsoring clinical trial NCT00209339?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.